Rigid ENT endoscope market seen topping $3.29 billion by 2030

The rigid ear, nose and throat endoscope market is forecast to grow from $2.18 billion in 2025 to $3.29 billion by 2030, driven by rising hearing disorders, minimally invasive procedures and AI-enabled imaging. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The rigid ENT endoscope market supports diagnosis and treatment of ear, nose and throat disorders, which are becoming more common as populations age. - Growing demand for minimally invasive procedures and better imaging is expanding use across hospitals, outpatient centers and surgical settings. - Rising hearing-loss cases make direct visualization tools more important for clinical assessment and treatment planning.

What happened: - The Business Research Company released its Global Market Report 2026 for rigid ear, nose and throat endoscopes. - The report pegs market size at $2.18 billion in 2025 and $2.38 billion in 2026. - The report forecasts the market will reach $3.29 billion by 2030. - The report puts the market’s 2025-2026 CAGR at 8.9% and the 2026-2030 CAGR at 8.5%. - North America was the largest market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - A rigid ENT endoscope is a straight, inflexible medical instrument used to view the ear, nose and throat. - The device combines a rigid metal tube, an optical lens system and an integrated light source. - Clinicians use the tool for magnified visualization of internal anatomical structures. - The report cites limited availability of advanced diagnostic imaging, dependence on open surgical diagnostic approaches and gradual hospital adoption as past growth drivers. - The report cites minimally invasive diagnostics, AI-enabled imaging and visualization, outpatient ENT surgical centers, precision medicine diagnostics and healthcare infrastructure investment as future growth drivers. - Expected market trends include high-definition imaging, AI-assisted diagnostic systems, minimally invasive ENT surgery, portable and compact endoscopic devices, and disposable infection-control accessories. - The report highlights rising hearing disorders as a major driver. - Centre for Inclusive Employment data from May 2026 showed about 3.6 million people in Australia have some degree of hearing loss, with the number projected to rise to nearly 7.8 million by 2060. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report also adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and updated technology and trend analysis. - Download a free sample of the report - View the full market report

Between the lines: - The market story is shifting from basic visualization tools toward smarter, more portable and more infection-conscious devices. - AI and high-definition imaging suggest vendors are competing on diagnostic precision rather than hardware alone. - The regional split points to a mature market in North America and faster adoption in Asia-Pacific as healthcare systems expand.

What's next: - Demand is likely to rise as ENT providers expand minimally invasive care and adopt more advanced imaging systems. - Product development will likely emphasize compact designs, disposable accessories and AI support. - Market growth will depend on healthcare investment, outpatient procedure growth and the pace of technology adoption.